OrganiGram Holdings Thursday Midday Brief: OGI BAT Partnership Capital and Automated Capacity Drive Q3 FY26 Canadian LP Thesis into Second-Half Inflection
TL;DR: OrganiGram Holdings (NASDAQ: OGI) heads into its Q3 FY2026 reporting period with a structurally improved cost position, a deepening strategic partnership with British American Tobacco that provides both capital access and international distribution optionality, and growing Canadian market share in the premium and value flower segments. The Moncton-based LP’s investment in automation and next-generation […]
Canopy Growth Thursday Morning Brief: CGC Nears Sub-Dollar Level Ahead of August 7 Earnings as Portfolio Rationalization Defines Q4 FY26 Thesis
TL;DR: Canopy Growth (CGC) closed Wednesday at $0.9487, hovering just below the $1.00 threshold, as the Canadian LP approaches its August 7 earnings date with a leaner asset base and a Q4 FY26 revenue consensus of $71.25M. With the BioSteel wind-down complete and legacy acquisition liabilities largely resolved, the August print will test whether portfolio […]
Curaleaf Holdings Wednesday Morning Brief: CURLF Posts 321 Percent One-Year Return as Q1 2026 Revenue Reaches 324 Million and August Earnings Approach
TL;DR: Curaleaf Holdings (CURLF), the largest U.S. cannabis multi-state operator by revenue, posted a 321.72% one-year return through mid-June 2026 as institutional interest in large-cap cannabis names accelerated on rescheduling positioning. With Q1 FY26 revenue of $324.23M and earnings scheduled for August 5, Curaleaf enters Q3 2026 as the highest-revenue MSO in the sector — […]
TerrAscend Corp Tuesday Midday Analysis: New Jersey Core Market and Multi-State Expansion Drive Q2 2026 Positioning
TL;DR: TerrAscend Corp (OTC: TSNDF) enters the back half of 2026 as a focused multi-state operator with New Jersey as its operational anchor, supplemented by growing scale in Pennsylvania, Maryland, and Michigan. The company’s Q2 2026 results will be scrutinized for evidence that its asset-light expansion approach is converting into meaningful free cash flow improvement […]
Cannabis Schedule III Rescheduling: DEA Final Rule Timeline and 280E Relief Mechanics as Q2 2026 Concludes
TL;DR: The cannabis sector closes Q2 2026 with Schedule III rescheduling still in DEA administrative adjudication, but multiple structural indicators suggest a final rule publication in the second half of the year remains achievable. The 280E tax relief that would follow rescheduling — estimated at hundreds of millions in aggregate annual tax savings across profitable […]
Cannabis Sector Q2 2026 Close: Key Metrics and Earnings Catalysts to Monitor as MSOs Book the Quarter
TL;DR: Cannabis equities are entering the final trading session of Q2 2026 on Tuesday with major multi-state operators stabilized near multi-quarter highs, underpinned by persistent rescheduling momentum and the prospect of 280E tax relief materializing in reported financials. Institutional positioning ahead of Q2 earnings — expected in August — will be the primary driver of […]
Cannabis Sector Monday Market Open: Q2 2026 Close Positions Major MSOs for Regulatory-Driven Q3 Catalyst Window
TL;DR: Cannabis equities close out Q2 2026 with sector-wide momentum building around the DEA’s Schedule III rescheduling rulemaking and renewed congressional support for the SAFER Banking Act, setting up major MSOs for a potential Q3 inflection. The removal of the Section 280E federal tax burden — the single most consequential near-term financial catalyst for plant-touching […]
AYR Wellness Sunday Close: Florida Recreational Momentum and 280E Relief Position Multi-State Operator for H2 2026 Recovery
TL;DR: AYR Wellness (OTC: AYRWF) enters the second half of 2026 with its largest market generating meaningful recreational cannabis revenue, a structural 280E cost tailwind from April’s federal medical rescheduling, and a deleveraging balance sheet that has materially improved operator visibility. With DEA adult-use rescheduling hearings approaching a record close, AYR sits at an inflection […]
Green Thumb Industries Sunday Midday Review: Dense Retail Network and Conservative Balance Sheet Define the Premier MSO Case
TL;DR: Green Thumb Industries (OTC: GTBIF) enters the final stretch of cannabis rescheduling proceedings as one of the sector’s most financially disciplined multi-state operators, with over 70 RISE dispensary locations, minimal debt, and an estimated $40–55 million annual 280E tax relief windfall at stake. Sunday’s midday session finds GTBIF holding near multi-year technical highs alongside […]
SAFER Banking Act 2026: Congressional Momentum Builds as Schedule III Rescheduling Reshapes the Cannabis Finance Landscape
TL;DR: The SAFER Banking Act — the cannabis industry’s most consequential pending financial legislation — is gaining renewed momentum in the 119th Congress as the DEA’s Schedule III administrative hearing nears its final evidentiary phase. With rescheduling expected to resolve the fundamental federal conflict over cannabis commerce, banking access reform is emerging as the logical […]